
Loading, please wait...

Loading, please wait...

Selecting the most effective ACL reconstruction autografts remains a critical decision for orthopedic surgeons worldwide. Historically, bone-patellar tendon-bone (BPTB) and hamstring tendon (HT) grafts were the primary choices for most cases. However, the quadriceps tendon (QT) has recently emerged as a robust and reliable alternative. A new meta-analysis of eleven randomized controlled trials evaluated these three options to clarify their clinical performance. Specifically, the study focused on patient-reported outcomes, joint stability, and overall complication rates in primary reconstructions.
The results showed no statistically significant differences in functional outcomes among the three groups. Specifically, pooled International Knee Documentation Committee (IKDC) scores averaged 84.8, while Lysholm scores reached 93.1. Furthermore, instrumented laxity tests revealed that side-to-side anterior tibial translation was consistent across all grafts, averaging 1.2 mm. These findings suggest that modern surgical techniques effectively achieve knee stability regardless of the autograft selected. Additionally, the analysis indicated that graft failure and reoperation rates were remarkably low across all included trials.
Regarding safety, the pooled graft failure rate across the study was only 0.7%. Moreover, reoperation rates remained around 2.3% without significant between-group differences. Interestingly, donor-site morbidity was comparable between the quadriceps and hamstring groups. However, the researchers noted that reporting for the BPTB group was often incomplete, which complicates direct comparisons for donor-site pain. Therefore, while QT appears to be a safe and effective option, surgeons should continue to consider individual patient profiles during the selection process. Consequently, these findings support the use of all three graft types as viable primary options.
No, high-level evidence suggests that quadriceps, hamstring, and bone-patellar tendon-bone autografts provide similar results regarding knee stability, patient-reported outcomes, and graft survival rates.
Studies show that quadriceps and hamstring tendons have similar donor-site morbidity profiles. However, some evidence suggests the quadriceps tendon may cause less donor-site pain compared to the patellar tendon grafts due to the lack of a bone block.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A meta-analysis of 11 RCTs shows no significant differences in clinical outcomes or stability among quadriceps, hamstring, and BPTB autografts for ACL surge...
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today